openPR Logo
Press release

Neurodiagnostics Market - Advances in Diagnosing Neurological Conditions | Forecast 2022-2030

07-18-2023 02:21 PM CET | Health & Medicine

Press release from: Ameco Research

Neurodiagnostics Market - Advances in Diagnosing Neurological

The global neurodiagnostics market has been exhibiting steady growth in recent years, driven by the rising cases of neurological disorders, continuous advances in brain imaging technologies and analytic techniques, growing geriatric population, and greater health awareness. Neurodiagnostics involves the use of a variety of non-invasive diagnostic tests and advanced imaging modalities to precisely diagnose conditions affecting the brain, spinal cord, peripheral nervous system, and muscles.

Neurodiagnostics Market Statistics and Highlights:

● The global neurodiagnostics market was valued at USD 7.1 billion in 2021. It is expected to reach USD 13.9 billion by 2030, registering a CAGR of 7.9% during the forecast period.
● North America held the largest revenue share exceeding 35% in 2021, attributed to advanced healthcare infrastructure and higher adoption of cutting-edge diagnostic technologies.

Download Sample Report Copy Of This Report From Here:
https://www.amecoresearch.com/sample/276827

Comprehensive Market Analysis:

The neurodiagnostics market outlook remains positive, majorly driven by the rising cases of neurological disorders like dementia, epilepsy, Parkinson's disease, stroke, migraine, and traumatic brain injuries globally. The COVID-19 pandemic also augmented the demand for diagnostic imaging and tests to manage various neurologic complications. Continuous technological advancements in structural and functional neuroimaging techniques like PET, SPECT, CT, MRI, EEG, MEG, and software analytics are creating significant growth opportunities. However, lack of adequately trained neurology healthcare professionals to operate complex diagnostic systems remains a key challenge.

Trends and Innovations in the Neurodiagnostics Market

● Integration of artificial intelligence and machine learning algorithms to improve imaging analysis, signal detection, and diagnostic accuracy.
● Development of hybrid diagnostic systems combining multiple imaging and testing modalities into a single platform.
● Growing research on neurochemical biomarker testing for early diagnosis of brain disorders.
● Rising adoption of teleradiology and telemedicine solutions enabling remote analysis of neurodiagnostic tests.
● Increasing focus on wearable and portable devices for continuous neurological monitoring and diagnostics.

Major Growth Drivers:

● Rising geriatric population who are at higher risk for neurodegenerative and age-related disorders like Alzheimer's, Parkinson's disease, stroke etc.
● Growing awareness regarding early diagnosis of neurological diseases to improve prognosis and outcomes.
● Increasing research and investments by companies to develop highly advanced neuroimaging and testing solutions.
● Favorable healthcare policies aimed at improving reimbursement for neurodiagnostic procedures.
● Rapidly growing burden of traumatic brain injuries requiring accurate diagnosis through imaging.
● Continuous technological advancements enabling point-of-care and portable neurodiagnostics.

Key Challenges Hindering Growth:

● High costs of advanced diagnostic imaging systems leading to affordability issues limiting adoption.
● Shortage of well-trained neurologists, radiologists, and technical staff required to optimally operate complex diagnostic systems.
● Low awareness regarding newer neurodiagnostic approaches particularly across developing regions with resource constraints.
● Requirement of frequent software upgrades and complex calibrations to keep pace with evolving technologies.
● Stringent regulatory frameworks in developed countries delaying new product approvals and launch timelines.

Market Segmentation Analysis:

The neurodiagnostic and monitoring devices market can be segmented by product type, condition treated, and end-user. Key product types in this market include cerebral oximeters, electroencephalogram (EEG) devices, electromyography (EMG) devices, intracranial pressure monitors, magnetoencephalography (MEG) devices, and transcranial cerebral oximeters. These devices are used to diagnose and monitor neurological conditions like epilepsy, headache disorders, neurodegenerative diseases, sleep disorders, stroke, and other diseases. The end-users for these neurodiagnostic tools include ambulatory care centers, diagnostic imaging centers, hospitals and surgery centers, neurology centers, and research laboratories and academic institutes.

Regional Market Analysis:

North America accounted for over 35% market share in 2021, driven by high healthcare spending, technological adoption, and leading players presence. Europe holds the second largest market position owing to rising brain disorder incidence and established reimbursement systems. The Asia Pacific market will exhibit the fastest CAGR over 2022-2030 owing to a vast patient pool, digital health infrastructure investments and improving access.

To check complete ToC please click here:
https://www.amecoresearch.com/neurodiagnostics-market/toc/276827

Leading Market Players:

GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems Corporation, Hitachi Ltd., Natus Medical Incorporated, Fujifilm Holdings Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., NeuroLogica Corp., IMRIS Inc. (Deerfield Imaging), Masimo Corporation, York Instruments Ltd., Neusoft Medical Systems Co., Ltd., Drägerwerk AG & Co. KGaA and Bruker Corporation.

Conclusion:

Driven by rising neurological disease prevalence and continuous technology innovation, the neurodiagnostics market outlook remains positive globally. Expanding geriatric populations and integration of AI will further boost growth over the coming years. However, the shortage of trained professionals remains a key concern. Leading companies are focused on launching integrated and advanced diagnostic systems to gain share.

To Purchase this Premium Report@
https://www.amecoresearch.com/buy/276827

201, Vaidehi-Saaket, Baner - Pashan Link Rd, Pashan, Pune, Maharashtra 411021

The complete information about our alliance publishers and the business verticals they cater to helps us in appropriately responding to our client requirements and identifying the potential opportunities in the market and suggest the research that can best suit client's requirement. Our comprehensive list of research reports boasts a complete collection of database casing almost every market category and sub-category.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neurodiagnostics Market - Advances in Diagnosing Neurological Conditions | Forecast 2022-2030 here

News-ID: 3135807 • Views:

More Releases from Ameco Research

HPAPI Market Spending on Track for USD 21.5 . Billion by 2032, Up 8.2CAGR
Introduction: High Potent Active Pharmaceutical Ingredients (HPAPIs) Market are compounds characterized by their high biological activity, necessitating stringent handling and manufacturing controls to ensure safety and efficacy. Recent trends in the pharmaceutical industry have spotlighted two significant aspects: the integration of artificial intelligence (AI) in HPAPI development and the implementation of advanced containment technologies. Request a free sample of our research report @ https://www.amecoresearch.com/sample/276609 How is Artificial Intelligence Transforming HPAPI Development? The pharmaceutical
Neurodiagnostics Market to Reach USD 13.9 Billion by 2030, Growing at a 7.9% CAGR | Insights and Forecast Till 2032
Neurodiagnostics Market to Reach USD 13.9 Billion by 2030, Growing at a 7.9% CAG …
Introduction: The global neurodiagnostics market is experiencing robust growth, fueled by the increasing prevalence of neurological disorders and technological advancements in diagnostic procedures. Valued at USD 7.1 billion in 2021, the market is projected to reach USD 13.9 billion by 2030, reflecting a compound annual growth rate (CAGR) of 7.9% from 2022 to 2030. This rise underscores the growing importance of neurodiagnostic tools, which are essential in diagnosing and monitoring conditions
Farm Equipment Rental Market to Reach USD 98.4 Billion by 2030: A Cost-Effective Solution for Modern Agriculture | Insights, Future Growth, and Opportunities
Farm Equipment Rental Market to Reach USD 98.4 Billion by 2030: A Cost-Effective …
Introduction The global farm equipment rental market is experiencing a notable growth trajectory. In 2021, the market was valued at USD 53.5 billion and is forecasted to nearly double, reaching USD 98.4 billion by 2030. This growth, at a steady CAGR of 7.1%, underscores the increasing demand for accessible, affordable agricultural machinery, which allows farmers to rent equipment like tractors, harvesters, sprayers, and specialized machinery for short or long-term use. As
Functional Apparel Market to Reach USD 691.2 Billion by 2030, Growing at a 7.2% CAGR - Key Trends, Opportunities, and Forecast Insights
Functional Apparel Market to Reach USD 691.2 Billion by 2030, Growing at a 7.2% …
Introduction: The global functional apparel market is experiencing exponential growth, driven by increasing consumer demand for multi-purpose clothing that combines comfort, style, and utility. The market, which was valued at USD 372.4 billion in 2021, is projected to reach USD 691.2 billion by 2030, with a compound annual growth rate (CAGR) of 7.2% from 2022 to 2030. This significant growth highlights the increasing adoption of functional apparel across industries such as

All 4 Releases


More Releases for Neurodiagnostics

Neurodiagnostics Market: Advancing Diagnostic Accuracy in Neurology
"In recent years, the global Neurodiagnostics Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neurodiagnostics Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including Porters Five
Neurodiagnostics Market: Advancing Diagnostic Accuracy in Neurology
In recent years, the global Neurodiagnostics Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neurodiagnostics Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including Porters Five
Neurodiagnostics Market Trends, Conditionrs, Restraints Forecast till 2030
The neurodiagnostics market encompasses a wide range of diagnostic tools and technologies used to diagnose neurological disorders and conditions, such as Alzheimer's disease, epilepsy, multiple sclerosis, and stroke. With the rising prevalence of neurological diseases and advancements in diagnostic technology, the market for neurodiagnostics is expanding rapidly. This article delves into the dynamic landscape of the global neurodiagnostics market, analyzing key trends, market drivers, challenges, regional insights, notable competitors, and
Neurodiagnostics Market Share, Size Forecast till 2030
According to Ameco Research 'Neurodiagnostics Market report, the analysts took this into account when estimating the Neurodiagnostics Market size and CAGR for the respective industry. The report's author has thoroughly examined the market and concluded that the Neurodiagnostics Market 's growth will level off in the coming years. In addition to that, the prominent qualitative information added in the report includes Neurodiagnostics Market trends, segmentation, key companies, SWOT, PORTER and
Neurodiagnostics Market Size, Share and Trends Analysis to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Neurodiagnostics Market Size, Share & Trends Analysis Report By Product (Diagnostic and Imaging Systems, Clinical Testing Instruments, Reagents & Consumables), By Condition (Neuro Degenerative Diseases, Epilepsy, Stroke), By End-Use (surgery centers, neurology centers, ambulatory care centers, diagnostic laboratories & imaging centers, and research laboratories & academic institutes)- Market Outlook And Industry Analysis 2031" The global neurodiagnostic
Neurodiagnostics Market Report Explored in Latest Research 2016 - 2023
Neurodiagnostics or neurodiagnostic tests monitor and record electrical activities of patient’s brain, spinal cord and peripheral nerves. The US National Institute of Mental Health (NIMH) estimates that approximately one in four individual suffers from diagnosable mental disorder each year. One in seventeen which is approximately 13.6 million people live with serious mental illnesses such as schizophrenia, major depression or bipolar disorder. Request Brochure- https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10247 Serious mental illness costs the United States approximately USD